Cycle Pharmaceuticals announced the launch of HARLIKU, the first and only FDA-approved treatment for reducing urinary ...

GSK has concluded the acquisition of efimosfermin alfa, an investigational therapeutic for serious liver disease (SLD), from ...

London: GSK plc has concluded the acquisition of efimosfermin alfa from Boston Pharmaceuticals in a USD 2 billion ...

GSK completes $2 billion acquisition of efimosfermin from Boston Pharmaceuticals: London, UK Wednesday, July 9, 2025, 09:00 Hrs [IST] GSK plc announced the completion of its previ ...

Boston Pharmaceuticals is launching with $600 million. Led by the former CEO of Sanofi, the company's focused on developing drugs ready to enter the clinic.

Boston Pharmaceuticals Announces Acceptance of Late-Breaking Abstract Highlighting New Phase 2 Clinical Data from BOS-580 NASH Program at EASL 2023 May 18, 2023 07:00 AM Eastern Daylight Time ...

Boston Pharmaceuticals To Present New Phase 2a Data From Investigational BOS-580 NASH Program at AASLD The Liver Meeting® 2023 November 07, 2023 09:44 AM Eastern Standard Time ...

A Cambridge biotech company is preparing to lay off its entire staff of more than 300 after being acquired by another firm.

BOSTON, June 9, 2025 – The Renaissance Boston Seaport District recently debuted its stunning new rooms… Scouting America is proud to announce that Bob Rivers, Executive Chair and Chair of the ...

Boston Pharmaceuticals today announces the appointment of Joanne Beck, Ph.D., as Chief Operating Officer. Dr. Beck joins Boston Pharmaceuticals from Celgene Corporation, where she was Executive ...

Pharmaceutical giant Eli Lilly on Tuesday announced plans to make a major investment and establish an Institute for Genetic Medicine in Boston.The Indianapolis-based company announced that it ...

Novartis AG (NOVN.EB) said Wednesday that it entered into a licensing and equity agreement with Boston Pharmaceuticals to develop three anti-infective drug candidates that are part of the Swiss ...